{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:07:25Z","timestamp":1790201245199,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RR210080"],"award-info":[{"award-number":["RR210080"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-91396-z","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T07:07:00Z","timestamp":1740812820000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["How modulation of the tumor microenvironment drives cancer immune escape dynamics"],"prefix":"10.1038","volume":"15","author":[{"given":"Pujan","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra S.","family":"Ghoreyshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason T.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,1]]},"reference":[{"key":"91396_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrc1295","volume":"4","author":"F Michor","year":"2004","unstructured":"Michor, F., Iwasa, Y. & Nowak, M. A. Dynamics of cancer progression. Nature reviews cancer 4, 197\u2013205 (2004).","journal-title":"Nature reviews cancer"},{"key":"91396_CR2","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1534\/genetics.105.049791","volume":"172","author":"Y Iwasa","year":"2006","unstructured":"Iwasa, Y., Nowak, M. A. & Michor, F. Evolution of resistance during clonal expansion. Genetics 172, 2557\u20132566 (2006).","journal-title":"Genetics"},{"key":"91396_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jtbi.2005.08.003","volume":"239","author":"N Komarova","year":"2006","unstructured":"Komarova, N. Stochastic modeling of drug resistance in cancer. Journal of theoretical biology 239, 351\u2013366 (2006).","journal-title":"Journal of theoretical biology"},{"key":"91396_CR4","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nm.4040","volume":"22","author":"AN Hata","year":"2016","unstructured":"Hata, A. N. et al. Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition. Nature medicine 22, 262\u2013269 (2016).","journal-title":"Nature medicine"},{"key":"91396_CR5","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nature11219","volume":"486","author":"LA Diaz Jr","year":"2012","unstructured":"Diaz, L. A. Jr. et al. The molecular evolution of acquired resistance to targeted egfr blockade in colorectal cancers. Nature 486, 537\u2013540 (2012).","journal-title":"Nature"},{"key":"91396_CR6","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1126\/science.342.6165.1432","volume":"342","author":"J Couzin-Frankel","year":"2013","unstructured":"Couzin-Frankel, J. Cancer immunotherapy. Science 342, 1432\u20131433 (2013).","journal-title":"Science"},{"key":"91396_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcancer.2005.07.008","volume":"16","author":"TL Whiteside","year":"2006","unstructured":"Whiteside, T. L. Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention. Seminars in cancer biology 16, 3\u201315 (2006).","journal-title":"Seminars in cancer biology"},{"key":"91396_CR8","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1126\/science.1203486","volume":"331","author":"RD Schreiber","year":"2011","unstructured":"Schreiber, R. D., Old, L. J. & Smyth, M. J. Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion. Science 331, 1565\u20131570 (2011).","journal-title":"Science"},{"key":"91396_CR9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jtbi.2018.09.012","volume":"458","author":"JT George","year":"2018","unstructured":"George, J. T. & Levine, H. Stochastic modeling of tumor progression and immune evasion. Journal of theoretical biology 458, 148\u2013155 (2018).","journal-title":"Journal of theoretical biology"},{"key":"91396_CR10","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1073\/pnas.1714478115","volume":"115","author":"S Palmer","year":"2018","unstructured":"Palmer, S., Albergante, L., Blackburn, C. C. & Newman, T. Thymic involution and rising disease incidence with age. Proceedings of the National Academy of Sciences 115, 1883\u20131888 (2018).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"91396_CR11","doi-asserted-by":"publisher","first-page":"P373","DOI":"10.1016\/j.trecan.2020.12.005","volume":"7","author":"JT George","year":"2021","unstructured":"George, J. T. & Levine, H. Implications of tumor-immune coevolution on cancer evasion and optimized immunotherapy. Trends in Cancer 7, P373-383 (2021).","journal-title":"Trends in Cancer"},{"key":"91396_CR12","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1158\/0008-5472.CAN-19-2732","volume":"80","author":"JT George","year":"2020","unstructured":"George, J. T. & Levine, H. Sustained coevolution in a stochastic model of cancer-immune interaction. Cancer research 80, 811\u2013819 (2020).","journal-title":"Cancer research"},{"key":"91396_CR13","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.82786","volume":"12","author":"JT George","year":"2023","unstructured":"George, J. T. & Levine, H. Optimal cancer evasion in a dynamic immune microenvironment generates diverse post-escape tumor antigenicity profiles. Elife 12, e82786 (2023).","journal-title":"Elife"},{"key":"91396_CR14","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cell.2018.03.057","volume":"173","author":"S Turajlic","year":"2018","unstructured":"Turajlic, S. et al. Tracking cancer evolution reveals constrained routes to metastases: Tracerx renal. Cell 173, 581\u2013594 (2018).","journal-title":"Cell"},{"key":"91396_CR15","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1056\/NEJMoa1616288","volume":"376","author":"M Jamal-Hanjani","year":"2017","unstructured":"Jamal-Hanjani, M. et al. Tracking the evolution of non-small-cell lung cancer. New England Journal of Medicine 376, 2109\u20132121 (2017).","journal-title":"New England Journal of Medicine"},{"key":"91396_CR16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","volume":"168","author":"N McGranahan","year":"2017","unstructured":"McGranahan, N. & Swanton, C. Clonal heterogeneity and tumor evolution: past, present, and the future. Cell 168, 613\u2013628 (2017).","journal-title":"Cell"},{"key":"91396_CR17","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/s41588-020-0687-1","volume":"52","author":"E Lakatos","year":"2020","unstructured":"Lakatos, E. et al. Evolutionary dynamics of neoantigens in growing tumors. Nature genetics 52, 1057\u20131066 (2020).","journal-title":"Nature genetics"},{"key":"91396_CR18","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.cell.2013.10.029","volume":"155","author":"FG Giancotti","year":"2013","unstructured":"Giancotti, F. G. Mechanisms governing metastatic dormancy and reactivation. Cell 155, 750\u2013764 (2013).","journal-title":"Cell"},{"key":"91396_CR19","doi-asserted-by":"publisher","first-page":"5014","DOI":"10.1158\/0008-5472.CAN-15-1370","volume":"75","author":"AC Yeh","year":"2015","unstructured":"Yeh, A. C. & Ramaswamy, S. Mechanisms of cancer cell dormancy-another hallmark of cancer?. Cancer research 75, 5014\u20135022 (2015).","journal-title":"Cancer research"},{"key":"91396_CR20","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3389\/fonc.2019.00498","volume":"9","author":"H-F Wang","year":"2019","unstructured":"Wang, H.-F. et al. Targeting immune-mediated dormancy: a promising treatment of cancer. Frontiers in oncology 9, 498 (2019).","journal-title":"Frontiers in oncology"},{"key":"91396_CR21","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1146\/annurev.immunol.22.012703.104803","volume":"22","author":"GP Dunn","year":"2004","unstructured":"Dunn, G. P., Old, L. J. & Schreiber, R. D. The three es of cancer immunoediting. Annu. Rev. Immunol. 22, 329\u2013360 (2004).","journal-title":"Annu. Rev. Immunol."},{"key":"91396_CR22","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJM200302063480620","volume":"348","author":"RM MacKie","year":"2003","unstructured":"MacKie, R. M., Reid, R. & Junor, B. Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery. New England Journal of Medicine 348, 567\u2013568 (2003).","journal-title":"New England Journal of Medicine"},{"key":"91396_CR23","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/nature06309","volume":"450","author":"CM Koebel","year":"2007","unstructured":"Koebel, C. M. et al. Adaptive immunity maintains occult cancer in an equilibrium state. Nature 450, 903\u2013907 (2007).","journal-title":"Nature"},{"key":"91396_CR24","doi-asserted-by":"crossref","unstructured":"Summers, M.\u00a0A., McDonald, M.\u00a0M. & Croucher, P.\u00a0I. Cancer cell dormancy in metastasis. Cold Spring Harbor Perspectives in Medicine 10 (2020).","DOI":"10.1101\/cshperspect.a037556"},{"key":"91396_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fimmu.2016.00020","volume":"7","author":"B Molon","year":"2016","unstructured":"Molon, B., Cal\u00ec, B. & Viola, A. T cells and cancer: how metabolism shapes immunity. Frontiers in immunology 7, 20 (2016).","journal-title":"Frontiers in immunology"},{"key":"91396_CR26","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00262-013-1429-3","volume":"62","author":"A Amedei","year":"2013","unstructured":"Amedei, A. et al. Ex vivo analysis of pancreatic cancer-infiltrating t lymphocytes reveals that eno-specific tregs accumulate in tumor tissue and inhibit th1\/th17 effector cell functions. Cancer Immunology, Immunotherapy 62, 1249\u20131260 (2013).","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"91396_CR27","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.immuni.2007.08.014","volume":"27","author":"X Cao","year":"2007","unstructured":"Cao, X. et al. Granzyme b and perforin are important for regulatory t cell-mediated suppression of tumor clearance. Immunity 27, 635\u2013646 (2007).","journal-title":"Immunity"},{"key":"91396_CR28","doi-asserted-by":"crossref","unstructured":"Whiteside, T.\u00a0L. The role of regulatory t cells in cancer immunology. ImmunoTargets and therapy 159\u2013171 (2015).","DOI":"10.2147\/ITT.S55415"},{"key":"91396_CR29","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3390\/cancers14051231","volume":"14","author":"R-P Czekay","year":"2022","unstructured":"Czekay, R.-P., Cheon, D.-J., Samarakoon, R., Kutz, S. M. & Higgins, P. J. Cancer-associated fibroblasts: mechanisms of tumor progression and novel therapeutic targets. Cancers 14, 1231 (2022).","journal-title":"Cancers"},{"key":"91396_CR30","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.3390\/cancers14163906","volume":"14","author":"RA Glabman","year":"2022","unstructured":"Glabman, R. A., Choyke, P. L. & Sato, N. Cancer-associated fibroblasts: Tumorigenicity and targeting for cancer therapy. Cancers 14, 3906 (2022).","journal-title":"Cancers"},{"key":"91396_CR31","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1189\/jlb.5VMR1116-493R","volume":"102","author":"A Hatziioannou","year":"2017","unstructured":"Hatziioannou, A., Alissafi, T. & Verginis, P. Myeloid-derived suppressor cells and t regulatory cells in tumors: unraveling the dark side of the force. Journal of Leukocyte Biology 102, 407\u2013421 (2017).","journal-title":"Journal of Leukocyte Biology"},{"key":"91396_CR32","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1158\/0008-5472.CAN-09-2587","volume":"70","author":"MK Srivastava","year":"2010","unstructured":"Srivastava, M. K., Sinha, P., Clements, V. K., Rodriguez, P. & Ostrand-Rosenberg, S. Myeloid-derived suppressor cells inhibit t-cell activation by depleting cystine and cysteine. Cancer research 70, 68\u201377 (2010).","journal-title":"Cancer research"},{"key":"91396_CR33","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3109\/08820139.2012.673191","volume":"41","author":"NR Monu","year":"2012","unstructured":"Monu, N. R. & Frey, A. B. Myeloid-derived suppressor cells and anti-tumor t cells: a complex relationship. Immunological investigations 41, 595\u2013613 (2012).","journal-title":"Immunological investigations"},{"key":"91396_CR34","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1158\/0008-5472.CAN-05-1299","volume":"66","author":"B Huang","year":"2006","unstructured":"Huang, B. et al. Gr-1+ cd115+ immature myeloid suppressor cells mediate the development of tumor-induced t regulatory cells and t-cell anergy in tumor-bearing host. Cancer research 66, 1123\u20131131 (2006).","journal-title":"Cancer research"},{"key":"91396_CR35","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.1182\/blood-2006-09-046201","volume":"109","author":"C Liu","year":"2007","unstructured":"Liu, C. et al. Expansion of spleen myeloid suppressor cells represses nk cell cytotoxicity in tumor-bearing host. Blood 109, 4336\u20134342 (2007).","journal-title":"Blood"},{"key":"91396_CR36","doi-asserted-by":"publisher","first-page":"20130010","DOI":"10.1098\/rsfs.2013.0010","volume":"3","author":"KP Wilkie","year":"2013","unstructured":"Wilkie, K. P. & Hahnfeldt, P. Mathematical models of immune-induced cancer dormancy and the emergence of immune evasion. Interface Focus 3, 20130010 (2013).","journal-title":"Interface Focus"},{"key":"91396_CR37","doi-asserted-by":"crossref","unstructured":"Wilkie, K.\u00a0P., Hahnfeldt, P. & Hlatky, L. Using ordinary differential equations to explore cancer-immune dynamics and tumor dormancy. bioRxiv 049874 (2016).","DOI":"10.1101\/049874"},{"key":"91396_CR38","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.immuni.2016.07.009","volume":"45","author":"NE Scharping","year":"2016","unstructured":"Scharping, N. E. et al. The tumor microenvironment represses t cell mitochondrial biogenesis to drive intratumoral t cell metabolic insufficiency and dysfunction. Immunity 45, 374\u2013388 (2016).","journal-title":"Immunity"},{"key":"91396_CR39","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","volume":"591","author":"MJ Watson","year":"2021","unstructured":"Watson, M. J. et al. Metabolic support of tumour-infiltrating regulatory t cells by lactic acid. Nature 591, 645\u2013651 (2021).","journal-title":"Nature"},{"key":"91396_CR40","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41571-018-0007-1","volume":"15","author":"KC Valkenburg","year":"2018","unstructured":"Valkenburg, K. C., de Groot, A. E. & Pienta, K. J. Targeting the tumour stroma to improve cancer therapy. Nat Rev Clin Oncol 15, 366\u2013381 (2018).","journal-title":"Nat Rev Clin Oncol"},{"key":"91396_CR41","unstructured":"Newton, P.\u00a0K. et al. Breast cancer modelling (2015). Website online available; accessed at 8\/14\/2024."},{"key":"91396_CR42","doi-asserted-by":"publisher","first-page":"15018","DOI":"10.1038\/npjbcancer.2015.18","volume":"1","author":"PK Newton","year":"2015","unstructured":"Newton, P. K. et al. Spatiotemporal progression of metastatic breast cancer: a markov chain model highlighting the role of early metastatic sites. npj Breast Cancer 1, 15018. https:\/\/doi.org\/10.1038\/npjbcancer.2015.18 (2015).","journal-title":"npj Breast Cancer"},{"key":"91396_CR43","unstructured":"Hasnain, Z. et al. Bladder cancer modelling (2019). Website online available; accessed at 8\/14\/2024."},{"key":"91396_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0210976","volume":"14","author":"Z Hasnain","year":"2019","unstructured":"Hasnain, Z. et al. Machine learning models for predicting post-cystectomy recurrence and survival in bladder cancer patients. PLOS ONE 14, 1\u201315. https:\/\/doi.org\/10.1371\/journal.pone.0210976 (2019).","journal-title":"PLOS ONE"},{"key":"91396_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40364-021-00333-5","volume":"9","author":"Z Hao","year":"2021","unstructured":"Hao, Z. et al. Landscape of myeloid-derived suppressor cell in tumor immunotherapy. Biomarker Research 9, 1\u201328 (2021).","journal-title":"Biomarker Research"},{"key":"91396_CR46","doi-asserted-by":"publisher","first-page":"7248","DOI":"10.3390\/ijms22147248","volume":"22","author":"H Gil-Julio","year":"2021","unstructured":"Gil-Julio, H. et al. Tumor escape phenotype in bladder cancer is associated with loss of hla class i expression, t-cell exclusion and stromal changes. International Journal of Molecular Sciences 22, 7248 (2021).","journal-title":"International Journal of Molecular Sciences"},{"key":"91396_CR47","first-page":"485","volume":"7","author":"Z Yang","year":"2021","unstructured":"Yang, Z. et al. Immune escape mechanisms and immunotherapy of urothelial bladder cancer. Journal of clinical and translational research 7, 485 (2021).","journal-title":"Journal of clinical and translational research"},{"key":"91396_CR48","doi-asserted-by":"publisher","first-page":"20200652","DOI":"10.1098\/rsif.2020.0652","volume":"17","author":"AP Browning","year":"2020","unstructured":"Browning, A. P., Warne, D. J., Burrage, K., Baker, R. E. & Simpson, M. J. Identifiability analysis for stochastic differential equation models in systems biology. Journal of the Royal Society Interface 17, 20200652 (2020).","journal-title":"Journal of the Royal Society Interface"},{"key":"91396_CR49","doi-asserted-by":"publisher","first-page":"20210426","DOI":"10.1098\/rspa.2021.0426","volume":"477","author":"S Martina-Perez","year":"2021","unstructured":"Martina-Perez, S., Simpson, M. J. & Baker, R. E. Bayesian uncertainty quantification for data-driven equation learning. Proceedings of the Royal Society A 477, 20210426 (2021).","journal-title":"Proceedings of the Royal Society A"},{"key":"91396_CR50","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1093\/bioinformatics\/btp358","volume":"25","author":"A Raue","year":"2009","unstructured":"Raue, A. et al. Structural and practical identifiability analysis of partially observed dynamical models by exploiting the profile likelihood. Bioinformatics 25, 1923\u20131929 (2009).","journal-title":"Bioinformatics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91396-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91396-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91396-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T07:53:00Z","timestamp":1740815580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91396-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["91396"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-91396-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.08.16.608314","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,1]]},"assertion":[{"value":"28 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7308"}}